NCT04610099

Brief Summary

A Sleeve Gastrectomy (SG) is on the long term not always successful in every patient because weight regain can occur. An intervention to prevent weight regain in the future is to place a silicone band (non-adjustable) around the sleeve (Banded-Sleeve Gastrectomy: BSG) which increases weight loss and decreases weight regain on the longer term. The question is whether primary application of a banded sleeve gives a greater weight loss and / or prevent weight regain in the future versus a standard sleeve gastrectomy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
211

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

June 28, 2024

Status Verified

June 1, 2024

Enrollment Period

5.3 years

First QC Date

October 26, 2020

Last Update Submit

June 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage Total Body Weight loss (%TBWL)

    ((preoperative weight - current weight) / (preoperative weight)) x 100%. Weight loss measured in kilograms

    3 years

Secondary Outcomes (6)

  • Percentage Excess Weight Loss (%EWL)

    3 years

  • Quality of life due to questionnaire

    3 years

  • Quality of life due to questionnaire

    3 years

  • Quality of life due to questionnaire

    3 years

  • Gastroesophageal reflux disease

    3 years

  • +1 more secondary outcomes

Study Arms (2)

Standard SG

ACTIVE COMPARATOR

100 patients undergo a standard sleeve gastrectomy

Device: Standard SG

Banded SG

EXPERIMENTAL

100 patients undergo a banded sleeve gastrectomy

Device: Banded Sleeve Gastrectomy

Interventions

banded sleeve gastrectomy

Also known as: BSG
Banded SG

Standard SG

Standard SG

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Alle patients who are eligible for a primary SG

You may not qualify if:

  • Bariatric surgery in medical history
  • BMI \> 60kg/m2 or a planned two-stage procedure.
  • Patients with a language barrier which may affect the compliance with medical advice
  • Patients with a disease not related to morbid obesity, such as Cushing or drug related.
  • Chronic bowel disease for example Crohn's disease or colitis Colitis.
  • Renal impairment (MDRD \<30) or hepatic dysfunction (liver function twice the normal values)
  • Pregnancy during follow-up
  • Patients with treatment-resistant reflux symptoms. Defined as reflux persistent symptoms despite the use of a minimum dose of proton-pump inhibitors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rijnstate Hospital

Arnhem, Gelderland, 6815AD, Netherlands

Location

Zuyderland Medisch Centrum

Heerlen, Limburg, 6419PC, Netherlands

Location

St. Antonius Ziekenhuis

Nieuwegein, Utrecht, 3435CM, Netherlands

Location

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hazebroek

    Rijnstate Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2020

First Posted

October 30, 2020

Study Start

September 1, 2020

Primary Completion

December 31, 2025

Study Completion

March 1, 2026

Last Updated

June 28, 2024

Record last verified: 2024-06

Locations